Logo.jpg
Biofrontera reports third quarter and first nine months 2020 results
November 11, 2020 07:00 ET | Biofrontera AG
Leverkusen, Germany, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today published its...
Logo.jpg
Biofrontera announces conference call to be held on November 12, 2020 to discuss Q3 2020 financial results
November 02, 2020 08:00 ET | Biofrontera AG
Leverkusen, Germany, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
Logo.jpg
Biofrontera AG: Receives reasons from the Federal Court of Justice for overturning ruling of the Cologne Higher Regional Court
October 14, 2020 04:30 ET | Biofrontera AG
Leverkusen, Germany, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, had announced on...
Logo.jpg
Biofrontera reports preliminary unaudited sales revenue for the third quarter of 2020
October 09, 2020 10:32 ET | Biofrontera AG
Leverkusen, Germany, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports...
Logo.jpg
Biofrontera AG reports completion of the clinical phase of the pharmacokinetics study
October 08, 2020 11:04 ET | Biofrontera AG
Leverkusen, Germany, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, reports the...
Logo.jpg
Biofrontera AG: German Federal Supreme Court overturns ruling of the Cologne Higher Regional Court
September 22, 2020 12:02 ET | Biofrontera AG
Leverkusen, Germany, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announces that in...
Logo.jpg
Biofrontera AG plans mediation to resolve (legal) disputes
September 11, 2020 07:33 ET | Biofrontera AG
Leverkusen, Germany, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-Group”), an international biopharmaceutical...
Logo.jpg
Biofrontera AG to participate in two upcoming conferences
September 09, 2020 08:00 ET | Biofrontera AG
Leverkusen, Germany, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be...
Logo.jpg
Biofrontera report results for the first six months of 2020
August 26, 2020 09:51 ET | Biofrontera AG
Leverkusen, Germany, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today published its...
Logo.jpg
Admission to trading of Biofrontera’s 1.00% qualified subordinated mandatory convertible bond 2020/2021
August 20, 2020 13:00 ET | Biofrontera AG
Leverkusen, Germany, Aug. 20, 2020 (GLOBE NEWSWIRE) -- On August 18, 2020, Biofrontera AG (shares of Biofrontera AG ISIN: DE 00 6046113) announced the successful placement of the 1.00% qualified...